CPRX
Catalyst Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +2.6% · netto nieuwe posities -5.3% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 107 | -4 | 76.77M | $2.41B | +12 | −18 |
| Q1 2026 | 116 | +4 | 78.68M | $1.95B | +8 | −4 |
| Q4 2025 | 111 | 0 | 78.17M | $1.82B | — | — |
| Q3 2025 | 19 | 0 | 48.11M | $947.78M | — | −1 |
| Q2 2025 | 17 | +1 | 43.29M | $939.35M | +1 | — |
| Q1 2025 | 13 | -1 | 14.99M | $363.56M | — | −1 |
| Q4 2024 | 14 | 0 | 15.06M | $314.25M | +1 | −1 |
| Q3 2024 | 13 | +3 | 9.07M | $180.23M | +4 | −1 |
| Q2 2024 | 10 | — | 9.29M | $143.84M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 18.22M | -3.6% | $358.86M | 0.0% | ▼ Trim | 2 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (passief) | 8.71M | -0.6% | $171.66M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passief) | 6.41M | +16.9% | $126.19M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 3.54M | +9.0% | $69.83M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passief) | 2.89M | +0.8% | $56.95M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Morgan Stanley ✦ | 1.84M | — | $36.32M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 7 | Arrowstreet Capital ✦ | 1.30M | +6.6% | $25.70M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | Millennium Management ✦ | 1.18M | +174.2% | $23.23M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 9 | Goldman Sachs Group ✦ | 1.01M | — | $19.84M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | JPMorgan Chase ✦ | 757.61K | — | $14.92M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 11 | T. Rowe Price ✦ | 743.67K | +1.1% | $14.65M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 12 | Citadel Advisors ✦ | 397.90K | +53.0% | $7.84M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 13 | Fidelity (FMR) ✦ | 362.22K | -28.9% | $7.14M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 14 | AQR Capital Management ✦ | 337.05K | -15.4% | $6.64M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 15 | Gotham Asset Management ✦ | 141.34K | +28.8% | $2.78M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 105.12K | +42.1% | $2.07M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 17 | Fisher Asset Management ✦ | 83.14K | 0.0% | $1.64M | 0.0% | Held | 6 | SEC ↗ |
| 18 | Wellington Management ✦ | 52.98K | +14.3% | $1.04M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 19 | Marshall Wace ✦ | 24.10K | -82.9% | $474,829 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Norges Bank | $298,722 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 378 houders, 103.75M aandelen, $2.50B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.